NMRA vs PSA
Neumora Therapeutics, Inc. (NMRA) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
PSA (PSA) common stock.
NMRA does not have a complete income-statement cache yet.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
NMRA currently screens at market cap $283.5M. PSA currently screens at market cap $0.
Not investment advice. Open the NMRA and PSA stock pages for the full models.
Not investment advice.